Literature DB >> 26865355

Intratumor heterogeneity in clear cell renal cell carcinoma: a review for the practicing pathologist.

José I López1.   

Abstract

Intertumor heterogeneity, defined as the spectrum of morphological differences found in similar tumors in different patients, is a well-known event for pathologists. However, recent molecular studies have pointed to intratumor heterogeneity as one of the most important issues in human neoplasia in the next years. Clear cell renal cell carcinoma is an example of an intrinsically heterogeneous neoplasm, and some of the most salient advances in the knowledge of intratumor heterogeneity have been developed on it. This review intends to analyze this phenomenon in this tumor from the practicing pathologist's point of view. A careful study of the surgical specimen and an exhaustive tumor sampling are mandatory to keep relevant information. Currently accepted protocols designed for renal tumor sampling may be insufficient. As a result, a different approach to tumor sampling is advisable to ascertain that intratumor heterogeneity, if present, will be well represented in the selected material.
© 2016 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Clear cell renal cell carcinoma; histopathology; immunohistochemistry; intratumor heterogeneity; molecular pathology

Mesh:

Year:  2016        PMID: 26865355     DOI: 10.1111/apm.12500

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  9 in total

1.  Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study.

Authors:  Matteo Brunelli; Guido Martignoni; Giorgio Malpeli; Alessandro Volpe; Luca Cima; Maria Rosaria Raspollini; Mattia Barbareschi; Alessandro Tafuri; Giulia Masi; Luisa Barzon; Serena Ammendola; Manuela Villanova; Maria Angela Cerruto; Michele Milella; Sebastiano Buti; Melissa Bersanelli; Giuseppe Fornarini; Sara Elena Rebuzzi; Valerio Gaetano Vellone; Gabriele Gaggero; Giuseppe Procopio; Elena Verzoni; Sergio Bracarda; Martina Fanelli; Roberto Sabbatini; Rodolfo Passalacqua; Bruno Perrucci; Maria Olga Giganti; Maddalena Donini; Stefano Panni; Marcello Tucci; Veronica Prati; Cinzia Ortega; Anna Caliò; Albino Eccher; Filippo Alongi; Giovanni Pappagallo; Roberto Iacovelli; Alessandra Mosca; Paolo Umari; Ilaria Montagnani; Stefano Gobbo; Francesco Atzori; Enrico Munari; Marco Maruzzo; Umberto Basso; Francesco Pierconti; Carlo Patriarca; Piergiuseppe Colombo; Alberto Lapini; Giario Conti; Roberto Salvioni; Enrico Bollito; Andrea Cossarizza; Francesco Massari; Mimma Rizzo; Renato Franco; Federica Zito-Marino; Yoseba Aberasturi Plata; Francesca Galuppini; Marta Sbaraglia; Matteo Fassan; Angelo Paolo Dei Tos; Maurizio Colecchia; Holger Moch; Maurizio Scaltriti; Camillo Porta; Brett Delahunt; Gianluca Giannarini; Roberto Bortolus; Pasquale Rescigno; Giuseppe Luigi Banna; Alessio Signori; Miguel Angel Llaja Obispo; Roberto Perris; Alessandro Antonelli
Journal:  J Pers Med       Date:  2022-04-30

Review 2.  Radiogenomics in Clear Cell Renal Cell Carcinoma: A Review of the Current Status and Future Directions.

Authors:  Sari Khaleel; Andrew Katims; Shivaram Cumarasamy; Shoshana Rosenzweig; Kyrollis Attalla; A Ari Hakimi; Reza Mehrazin
Journal:  Cancers (Basel)       Date:  2022-04-22       Impact factor: 6.575

Review 3.  DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.

Authors:  Javier C Angulo; Jose I López; Santiago Ropero
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

Review 4.  The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments.

Authors:  Javier C Angulo; Claudia Manini; Jose I López; Angel Pueyo; Begoña Colás; Santiago Ropero
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

5.  Multi-site tumor sampling (MSTS) improves the performance of histological detection of intratumor heterogeneity in clear cell renal cell carcinoma (CCRCC).

Authors:  Rosa Guarch; Jesús M Cortés; Charles H Lawrie; José I López
Journal:  F1000Res       Date:  2016-08-17

6.  von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.

Authors:  Lucas Tedesco; Belén Elguero; David Gonilski Pacin; Sergio Senin; Cora Pollak; Patricio A Garcia Marchiñena; Alberto M Jurado; Mariana Isola; María J Labanca; Martin Palazzo; Patricio Yankilevich; Mariana Fuertes; Eduardo Arzt
Journal:  Cell Death Dis       Date:  2019-03-19       Impact factor: 8.469

7.  Clinicopathological and Molecular Characteristics of Macroscopically Yellowish-Colored Chromophobe Renal Cell Carcinoma Compared to Non-Yellowish-Colored Chromophobe Renal Cell Carcinoma.

Authors:  Fumiyoshi Kojima; Ibu Matsuzaki; Naoto Kuroda; Yurina Mikasa; Fidele Y Musangile; Ryuta Iwamoto; Yuichi Takahashi; Akiko Matsubara; Yasuo Kohjimoto; Isao Hara; Shin-Ichi Murata
Journal:  Clin Pathol       Date:  2021-12-12

8.  Features of increased malignancy in eosinophilic clear cell renal cell carcinoma.

Authors:  Helén Nilsson; David Lindgren; Håkan Axelson; Christian Brueffer; Lao H Saal; Jaana Lundgren; Martin E Johansson
Journal:  J Pathol       Date:  2020-09-24       Impact factor: 7.996

9.  Upregulated circPDK1 Promotes RCC Cell Migration and Invasion by Regulating the miR-377-3P-NOTCH1 Axis in Renal Cell Carcinoma.

Authors:  Zhenlin Huang; Yinghui Ding; Lu Zhang; Siyuan He; Zhankui Jia; Chaohui Gu; Tao Wang; Hao Li; Xiang Li; Zhibo Jin; Yafei Ding; Jinjian Yang
Journal:  Onco Targets Ther       Date:  2020-11-03       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.